Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA
Journal of Hepatology Mar 21, 2019
Hernaez R, et al. - In a large cohort of patients with acute-on-chronic liver failure (ACLF) in the US, researchers analyzed the prevalence and risk factors correlated with the development and short term mortality. Patients with ACLF were identified during hospitalisation for decompensated cirrhosis at any of the 127 VA hospitals between January 1, 2004, and December 31, 2014, using the US Department of Veterans Affairs (VA) Corporate Data Warehouse. They examined ACLF prevalence and variables associated with 28- and 90-day mortality in ACLF, as well as trends in prevalence and survival over time. Findings suggested an association of older age, White race, liver cancer, higher model for end-stage liver disease sodium corrected score, and non-liver transplant centre with an increased risk of death in ACLF. Overall, the investigators suggested that ACLF was common and linked to high short-term mortality in a US cohort of hospitalised patients with decompensated cirrhosis. ACLF prevalence has decreased over a decade, but ACLF-3 survival improvement has not been seen. Early recognition and aggressive management may lead to improved outcomes in ACLF, including timely referral to transplant centres.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries